New drug development--expectations and speculations.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D004339:Drug Compounding; D004341:Drug Evaluation; D004358:Drug Therapy; D004791:Enzyme Inhibitors; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D010600:Pharmacology; D010907:Pituitary Hormones / Q000627:therapeutic use; D010919:Placebos; D011453:Prostaglandins / Q000627:therapeutic use; D012106:Research; D012651:Self Medication; D014149:Tranquilizing Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000900:Anti-Bacterial Agents; D000928:Antidepressive Agents; D004791:Enzyme Inhibitors; D006634:Histamine H1 Antagonists; D010907:Pituitary Hormones; D010919:Placebos; D011453:Prostaglandins; D014149:Tranquilizing Agents